Literature DB >> 955338

Gastric inhibitory polypeptide (GIP), gastrin and insulin: response to test meal in coeliac disease and after duodeno-pancreatectomy.

W Creutzfeldt, R Ebert, R Arnold, H Freichs, J C Brown.   

Abstract

The response of serum immunoreactive gastric inhibitory polypeptide (IR-GIP), gastrin (IRG) and insulin (IRI) to a mixed standard meal was measured in 15 controls, 6 patients with coeliac disease, 26 patients with chronic pancreatitis and partial duodenopancreatectomy (Whipple's procedure). Serum levels of IR-GIP, IRG and IRI were significantly reduced in patients with coeliac disease. The serum glucose increase was significantly smaller only during the first hour after the meal. Since small intestinal GIP- and G-cells are situated mainly in the glands of duodenal and jejunal mucosa their absolute number is not significantly reduced in coeliac disease. It is suggested that the release of IR-GIP and duodenal IRG is influenced by the rate of absorption of nutrients. In patients with chronic pancreatitis the IR-GIP release is significantly greater than in controls, the IRG release normal and the IRI response delayed. After Whipple's procedure the IR-GIP response is increased significantly while the IRG secretion is abolished. This demonstrates that the duodenum is not necessary for GIP release and that pancreatic and jejunal gastrin are without clinical significance.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 955338     DOI: 10.1007/BF00422096

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  18 in total

1.  Release of immunoreactive gastric inhibitory polypeptide (IR-GIP) by oral ingestion of food substances.

Authors:  I G Cleator; R H Gourlay
Journal:  Am J Surg       Date:  1975-08       Impact factor: 2.565

Review 2.  Identification and actions of gastric inhibitory polypeptide.

Authors:  J C Brown; J R Dryburgh; S A Ross; J Dupré
Journal:  Recent Prog Horm Res       Date:  1975

Review 3.  Candidate hormones of the gut. XV. Insulin-releasing factors of the gastrointestinal mucosa (Incretin).

Authors:  M Creutzfeldt
Journal:  Gastroenterology       Date:  1974-10       Impact factor: 22.682

4.  Cellular localization of gastric inhibitory polypeptide in the duodenum and jejunum.

Authors:  J M Polak; S R Bloom; M Kuzio; J C Brown; A G Pearse
Journal:  Gut       Date:  1973-04       Impact factor: 23.059

5.  Stimulation of insulin secretion by gastric inhibitory polypeptide in man.

Authors:  J Dupre; S A Ross; D Watson; J C Brown
Journal:  J Clin Endocrinol Metab       Date:  1973-11       Impact factor: 5.958

6.  Effect of intravenous tolbutamide on serum insulin levels in pancreatic diabetes.

Authors:  B I Joffe; S Bank; W P Jackson; A I Vinik; P Keller
Journal:  Diabetes       Date:  1969-07       Impact factor: 9.461

7.  Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man.

Authors:  J M Falko; S E Crockett; S Cataland; E L Mazzaferri
Journal:  J Clin Endocrinol Metab       Date:  1975-08       Impact factor: 5.958

8.  [On radio-immunologic determination of insulin in blood].

Authors:  F Melani; H Ditschuneit; K M Bartelt; H Friedrich; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1965-09-15

9.  Secretin cells in coeliac disease.

Authors:  J M Polak; A G Pearse; S Van Noorden; S R Bloom; M A Rossiter
Journal:  Gut       Date:  1973-11       Impact factor: 23.059

10.  Gastrin release in postoperative ulcer patients: evidence for release of duodenal gastrin.

Authors:  D H Stern; J H Walsh
Journal:  Gastroenterology       Date:  1973-03       Impact factor: 22.682

View more
  24 in total

Review 1.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

2.  Effect of massive bowel resection on enteroinsular axis.

Authors:  T Kajawara; T Szuki; T Tobe
Journal:  Gut       Date:  1979-09       Impact factor: 23.059

3.  Factors influencing insulin secretion after pancreatoduodenectomy.

Authors:  K Kasahara; Y Yamashita; H Ishibashi; T Fukumoto; S Tenmoku; A Kashii; K Kanazawa
Journal:  Jpn J Surg       Date:  1987-11

4.  Adrenergic modulation of gastric inhibitory polypeptide secretion in man.

Authors:  M Salera; R Ebert; P Giacomoni; L Pironi; S Venturi; R Corinaldesi; M Miglioli; L Barbara
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

5.  Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia.

Authors:  R Ebert; W Creutzfeldt
Journal:  Acta Diabetol Lat       Date:  1989 Jan-Mar

6.  Gastric function and absorption of vitamin B12 in children with celiac disease.

Authors:  J Kokkonen; S Similä
Journal:  Eur J Pediatr       Date:  1979-10       Impact factor: 3.183

7.  Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.

Authors:  D K Andersen; D Elahi; J C Brown; J D Tobin; R Andres
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

8.  Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) in man.

Authors:  A M Buchan; J M Polak; C Capella; E Solcia; A G Pearse
Journal:  Histochemistry       Date:  1978-06-02

9.  Glucose-dependent insulinotropic peptide: structure of the precursor and tissue-specific expression in rat.

Authors:  C C Tseng; L A Jarboe; S B Landau; E K Williams; M M Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

Review 10.  Clinical aspects of GIP secretion.

Authors:  B Beck; C Villaume; G Debry
Journal:  Acta Diabetol Lat       Date:  1982 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.